AVEO Historical Earnings image   This AVEO historical earnings page last updated 11/8/2022
AVEO Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202211/7/20220.03B
Q2 20228/4/20220.03B
Q1 20225/5/20220.02B
Q4 20213/14/20220.02B
Q3 202111/8/20210.02B
Q2 20218/5/20210.01B
Q1 20215/10/20210.00B
Q4 20203/16/20210.00B
Q3 202011/9/20200.00B
Q2 20208/10/20200.00B
Q1 20204/30/20200.00B
Q4 20193/16/20200.00B
Q3 201911/12/20190.03B
Q2 20198/8/20190.00B
Q1 20195/9/20190.00B
Q4 20183/14/20191.48M
Q3 201811/9/20182.47M
Q2 20188/7/2018433000
Q1 20185/8/20181.03M
Q4 20173/13/201882000
Q3 201711/7/20174.61M
Q2 20178/9/2017351000
Q1 20175/4/20172.53M
Q4 20163/22/2017127000
Q3 201611/4/2016992000
Q2 20168/4/2016193000
Q1 20165/10/20161.20M
Q4 20153/15/20163.60M
Q3 201511/9/2015134000
Q2 20158/10/2015134000
Q1 20155/7/2015134000
Q4 20143/6/2015115000
Q3 201411/5/2014873000
Q2 20148/11/20141.85M
Q1 20145/7/201415.30M
Q4 20133/13/2014323000
Q3 201311/7/2013323000
Q2 20138/8/2013324000
Q1 20134/29/2013323000
Q4 20122/13/201315.53M
Q3 201210/30/20121.02M
Q2 20128/2/20121.88M
Q1 20125/3/2012860000
AVEO Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202211/7/2022-0.090
Q2 20228/4/2022-0.240
Q1 20225/5/2022-0.300
Q4 20213/14/2022-0.210
Q3 202111/8/2021-0.300
Q2 20218/5/2021-0.400
Q1 20215/10/2021-0.810
Q4 20203/16/2021-0.440
Q3 202011/9/2020-0.330
Q2 20208/10/2020-0.420
Q1 20204/30/2020-0.520
Q4 20193/16/2020-0.280
Q3 201911/12/20191.000
Q2 20198/8/2019-0.200
Q1 20195/9/2019-0.600
Q4 20183/14/2019-0.300
Q3 201811/9/2018-1.800
Q2 20188/7/2018-0.600
Q1 20185/8/2018-0.800
Q4 20173/13/2018-0.600
Q3 201711/7/2017-2.200
Q2 20178/9/2017-0.800
Q1 20175/4/2017-1.200
Q4 20163/22/2017-0.700
Q3 201611/4/2016-0.700
Q2 20168/4/2016-1.300
Q1 20165/10/2016-1.300
Q4 20153/15/2016-1.100
Q3 201511/9/2015-1.000
Q2 20158/10/2015-1.000
Q1 20155/7/2015-2.100
Q4 20143/6/2015-2.700
Q3 201411/5/2014-2.800
Q2 20148/11/2014-3.500
Q1 20145/7/2014-1.200
Q4 20133/13/2014-3.200
Q3 201311/7/2013-4.700
Q2 20138/8/2013-6.200
Q1 20134/29/2013-6.900
Q4 20122/13/2013-4.900
Q3 201210/30/2012-6.900
Q2 20128/2/2012-6.800
Q1 20125/3/2012-7.700
Quotes delayed 20 minutes

Email EnvelopeFree AVEO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
AVEO Pharmaceuticals (AVEO) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

AVGR Historical Earnings
AVIR Historical Earnings
AVNS Historical Earnings
AVRO Historical Earnings
AVTE Historical Earnings
AVTX Historical Earnings
AVXL Historical Earnings
AWH Historical Earnings
AXDX Historical Earnings
AXGN Historical Earnings
What was the record high AVEO historical earnings result?
In terms of earnings or revenue, what is the best AVEO historical earnings result that AVEO Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest AVEO historical earnings result was set in Q3 2019, when AVEO Pharmaceuticals posted results of 1.000/share. The most successful revenue quarter within our data set was Q3 2022 when AVEO Pharmaceuticals reported revenue of 0.03B.

What was the lowest AVEO Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest AVEO has reported, and when?

✔️Accepted answer: Within our data set, the lowest AVEO historical earnings result was set in Q1 2012, when AVEO Pharmaceuticals posted results of -7.700/share. The smallest revenue quarter within our data set was Q4 2017 when AVEO Pharmaceuticals reported revenue of 82000.

On this page we presented the AVEO historical earnings date information for AVEO Pharmaceuticals. Reviewing that AVEO Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2019, when AVEO posted gaap of 1.000/share. Meanwhile the lowest AVEO historical earnings result was in Q1 2012, when AVEO posted gaap of -7.700/share. Moving to AVEO Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q3 2022 when AVEO reported 0.03B in revenue, while the smallest revenue quarter was Q4 2017 when AVEO reported 82000 in revenue.

For self directed investors doing their due diligence on AVEO or any other given stock, their research can benefit from looking into all of the AVEO Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into AVEO Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for AVEO. Thanks for visiting, and the next time you need to research AVEO historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Funds Holding DNLI, EOSE Videos, Top Ten Hedge Funds Holding KINS.


AVEO Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.